Advagene Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,885	1,220	1,355	1,479	2,396	1,467
Market Cap Growth	54.50%	-9.95%	-8.37%	-38.27%	63.30%	65.89%
Enterprise Value	1,722	1,130	1,294	1,322	2,125	1,259
Last Close Price	31.75	20.55	25.40	29.73	48.31	32.75
PB Ratio	10.06	5.53	9.68	11.22	9.60	4.90
P/TBV Ratio	10.06	5.53	9.68	12.13	9.96	5.14
Debt / Equity Ratio	0.02	0.03	-	0.02	0.02	0.02
Quick Ratio	30.73	31.56	18.25	14.51	29.07	23.32
Current Ratio	30.83	31.63	18.37	14.94	29.50	23.47
Return on Equity (ROE)	-48.04%	-38.51%	-67.80%	-62.09%	-33.77%	-24.59%
Return on Assets (ROA)	-28.28%	-23.29%	-40.40%	-37.32%	-20.47%	-15.91%
Return on Capital Employed (ROCE)	-38.30%	-31.50%	-66.70%	-90.50%	-37.50%	-25.00%
Earnings Yield	-3.77%	-5.69%	-6.80%	-8.00%	-3.87%	-4.78%
FCF Yield	-4.09%	-5.83%	-5.73%	-7.41%	-2.83%	-2.15%
Buyback Yield / Dilution	-10.02%	-8.47%	-2.14%	-1.23%	-9.95%	-0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.